Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis

Journal of Neuroimmunology

Volumn 32, Issue 1, 1991, Pages 67-74

  Maimone, Davide ^a   Gregory, Susan ^a   Arnason, Barry G W ^a   Reder, Anthony T ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Cerebrospinal fluid; Cytokine; Interleukin 1; Interleukin 6; Multiple sclerosis; Tumor necrosis factor

Indexed keywords

CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL;

ADULT; CYTOKINES; FEMALE; HUMAN; INFLAMMATION; INTERLEUKIN-1; INTERLEUKIN-6; MALE; MULTIPLE SCLEROSIS; NERVOUS SYSTEM DISEASES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR NECROSIS FACTOR;

EID: 0026066932     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-5728(91)90073-G     Document Type: Article

References (46)

1. Production of hybridoma growth factor by human monocytes
2. Action of recombinant human interleukin-6, interleukin-1β and tumor necrosis factorα on the mRNA induction of acute phase proteins
3. Cell-mediated immunity and neurologic disease
4. Tumor necrosis factor-α enhances interferon-γ mediated class II antigen expression on astrocytes
5. Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines
6. Interleukin-1 and its biologically related cytokines
7. Multiple biological activities of human recombinant interleukin 1
8. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin-1
9. Macrophage-derived mediators: interleukin 1, tumor necrosis factor, interleukin 6, interferon, and related cytokines
10. Visualization and characterization of interleukin 1 receptors in brain
11. Tumor necrosis factor in serum and cerebrospinal fluid of patients with multiple sclerosis
12. Production of B cell stimulatory factor-2 and interferon gamma in the central nervous system during viral meningitis and encephalitis. Evaluation in a murine model infection and in patients
13. On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases
14. Tumor necrosis factor alpha (TNFα) and neurological diseases. Failure in detecting TNFα in the cerebrospinal fluid from patients with multiple sclerosis, AIDS dementia complex, and brain tumorsv
15. IL-1 induces IL-1. III. Specific inhibition of IL-1 production by IFN-γ
16. Interleukin 6 production in the central nervous system during experimental autoimmune encephalomyelitis
17. Interleukin-1 stimulation of astroglial proliferation after brain injury
18. Interleukin 6 is involved in interleukin 1-induced activities
19. Arthritogenic actions of recombinant IL-1 and tumor necrosis factor α in the rabbit: evidence for synergistic interactions between cytokines in vivo
20. Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis
21. Immunoregulatory molecules and IL-2 receptors identified in multiple sclerosis brain
22. Tumor necrosis factor identified in multiple sclerosis brain
23. Cytokines in synovial fluid. I. The presence of biologically active and immunoreactive IL-1
24. Elevated levels of the 26K human hybridoma growth factor (interleukin 6) in cerebrospinal fluid of patients with acute infection of the central nervous system
25. Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells
26. Tumor necrosis factor induces the expression of MHC class I antigens on mouse astrocytes
27. Tumor necrosis factor alpha in the cerebrospinal fluid during bacterial, but not viral meningitis. Evaluation in murine model infections and in patients
28. Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus
29. Human tumor necrosis factor potentiates human interleukin-1-mediated rat pancreatic β-cell cytotoxicity
30. IL-6/BSF2 in normal and abnormal regulation of immune responses
31. Detection of circulating tumor necrosis factor after endotoxin administration
32. The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells
33. Neuroendocrine interactions with interleukin-1 inflammation
34. Detection of in vivo stimulated cerebrospinal-fluid lymphocytes by flow cytometry in patients with multiple sclerosis
35. New diagnostic criteria for multiple sclerosis: guidelines for research protocols
36. Multiple sclerosis: capping of surface immunoglobulin G on macrophages engaged in myelin breakdown
37. Immunology of multiple sclerosis
38. Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes
39. Detection of tumor necrosis factor α but not tumor necrosis factor β in rheumatoid arthritis and other inflammatory arthritides
40. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF
41. Tumor necrosis factor mediates myelin damage in vitro
42. Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor
43. Recombinant tumor necrosis factor and interleukin-1 enhance slow wave sleep
44. Multiple sclerosis. Distribution of T cells, T cell subsets and Ia-positive macrophages in lesions of different ages
45. The complex pattern of cytokines in serum from patients with meningococcal septic shock
46. Local production of tumor necrosis factor α, interleukin 1, and interleukin 6 in meningococcal meningitis